Fig. 3From: Retrospective analysis of safety and efficacy of enhanced recovery pathways in stage II–III colorectal cancer patients submitted to surgery and adjuvant therapyHospital stays analysis. *Shorter days/patient than those of CSLFO and OSLFO cohorts. #Shorter days/patient than those of OSLFO cohortBack to article page